Multaq 400 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FXANM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,275
Award facts
- Contract value 100% obligated
- $27,274.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Multaq (dronedarone) 400 mg tablets in a 60-count package. This is a firm fixed-price delivery order with a ceiling value of $27,274.96 and an ultimate completion date of September 29, 2025. The award is not set-aside and was competitively awarded. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026, which enables the company to supply a broad range of medications and medical commodities to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical vendor, fulfills pharmaceutical procurement needs across the Defense Health Agency and other government healthcare systems. The company's federal contract portfolio demonstrates extensive experience delivering brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The Multaq delivery under this order supports the company's ongoing role as a pharmaceutical prime vendor for the Defense Logistics Agency's global medical supply chain, serving military personnel and veteran healthcare requirements.
Quick answers
Who was awarded contract SPE2DB25FXANM?
SPE2DB25FXANM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FXANM worth?
The government has obligated $27,275 on SPE2DB25FXANM.
Is contract SPE2DB25FXANM an order under another contract?
Yes. SPE2DB25FXANM is a delivery order under SPE2DB25D3012, an indefinite delivery contract.
Was contract SPE2DB25FXANM competed?
The extent of competition for SPE2DB25FXANM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award